Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
31,451,376
-
Shares change
-
+10,773,756
-
Total reported value, excl. options
-
$546,085,663
-
Value change
-
+$188,712,886
-
Number of buys
-
68
-
Number of sells
-
-10
-
Price
-
$17.52
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q2 2020
83 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q2 2020.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,451,376 shares
of 94,179,674 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include FMR LLC (4,926,835 shares), PERCEPTIVE ADVISORS LLC (3,659,381 shares), ORBIMED ADVISORS LLC (2,753,567 shares), RA CAPITAL MANAGEMENT, L.P. (2,328,698 shares), Vivo Capital, LLC (2,316,628 shares), Versant Venture Management, LLC (2,030,616 shares), BlackRock Inc. (1,767,869 shares), 5AM Venture Management, LLC (1,362,286 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,347,000 shares), and VANGUARD GROUP INC (1,081,036 shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.